Treating patients with anticoagulants and antiplatelet drugs is always a balance between risk for thrombosis vs. risk for bleeding.

Agewall, Stefan

Agewall, Stefan.

Agewall S; Editor-in-Chief, Oslo University Hospital Ullevål and Institute of Clinical Sciences, University of Oslo, Oslo, Norway.

Eur Heart J Cardiovasc Pharmacother ; 8(7): 645-647, 2022 Sep 29.

Article in English | MEDLINE | ID: covidwho-2312213

Subject(s)

Platelet Aggregation Inhibitors; Thrombosis; Anticoagulants/adverse effects; Hemorrhage/chemically induced; Humans; Platelet Aggregation Inhibitors/adverse effects; Thrombosis/diagnosis; Thrombosis/drug therapy; Thrombosis/prevention & control

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombosis / Platelet Aggregation Inhibitors Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Eur Heart J Cardiovasc Pharmacother Year: 2022 Document Type: Article Affiliation country: Ehjcvp

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google